bioRxivMicrobiologyPreprint
Serial passage of the human probiotic E. coli Nissle 1917 in an insect host leads to changed bacterial phenotypes
N. C. H. Schröder, A. Korsa, H. Wami, U. Dobrindt, J. Kurtz
Abstract
Probiotics are living microorganisms that are increasingly and successfully used for the therapy of various diseases. The most common use of probiotics is the therapeutic and preventive application for gastrointestinal disorders. The probiotic Escherichia coli strain Nissle 1917 (EcN) has been proven to effectively prevent and alleviate intestinal diseases, including various types of inflammatory bowel disease. Despite the widespread medical application of EcN, the underlying mechanisms of its protective effect remain elusive. The present work aimed to establish an insect model system to enable further research on the modes of action of EcN and the dynamics of adaptation to a novel host organism. Using a long-term serial passage approach, we orally introduced EcN to the host, the red flour beetle Tribolium castaneum. After multiple cycles of intestinal colonization in beetle larvae, several attributes of the passaged replicate lines were assessed. We observed phenotypic changes in growth and motility but no genetic changes in the lines after passaging through the host and its flour environment. One of the EcN lines exposed to the host displayed peculiar morphological and physiological characteristics showing that serial passage of EcN can generate differential phenotypes.
- organism: Drosophila
- assay: bulk RNA-seq
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Adaptive strategies of the candidate probiotic E. coli Nissle in the mammalian gut
N. Crook, A. Ferreiro, … G. Dantas·bioRxiv·Jul 9, 2018
- Construction of an engineered Escherichia coli with enhanced intestinal colonization and anti-inflammatory efficacy in colitis
Peijun Yu, Wenjing Zhou, … Yunpeng Yang·bioRxiv·Aug 1, 2025
- Enhancing the antibacterial function of probiotic Escherichia coli Nissle: when less is more
E. Bartram, M. Asai, … R. Wigneshweraraj·bioRxiv·Jun 9, 2023
- Gut microbiota modulation in response to combination of Escherichia coli Nissle 1917 and sugars: Lessons from comparative analysis of fecal microbiota of two healthy donors from 2019-2021
D. Bhowmik, K. Heer, … S. Paul·bioRxiv·Jun 10, 2022
- Escherichia coli Nissle 1917 occupies previously undocumented host niches in the insect-parasitic nematode Steinernema hermaphroditum
Victoria Chen, John P. Marken, … Mengyi Cao·Environmental Microbiology ReportsPeer-reviewed·Apr 1, 2026
- Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system